Predictors of Severe COVID-19 in Patients With Diabetes: A Multicenter Review
- 1 August 2021
- journal article
- review article
- Published by Elsevier in Endocrine Practice
- Vol. 27 (8) , 842-849
Abstract
No abstract availableKeywords
Funding Information
- Institute for Clinical and Translational Research, University of Wisconsin, Madison
- National Center for Advancing Translational Sciences (1UL1TR003098)
This publication has 12 references indexed in Scilit:
- Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deathsDiabetes Research and Clinical Practice, 2021
- Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational StudyDiabetes Care, 2020
- Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019Diabetes Care, 2020
- In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19Cell Metabolism, 2020
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisJournal of Infection, 2020
- Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort studyCritical Care, 2020
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyDiabetologia, 2020
- Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United StatesJournal of Diabetes Science and Technology, 2020
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 DiabetesCell Metabolism, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020